Substance use is a persistent concern for adolescents in many countries due to the significant negative impact on mental, physical and social outcomes. US research indicates that while 4.1% of 12–17‐year‐olds require treatment, <10% of those who require it access it. This paper summarises the literature available on the barriers and enablers to those under 18s attending substance use treatment to inform policy and practice. Using a systematic approach, we searched six databases for studies which reported barriers and enablers to those aged 18 and under accessing substance use treatment. Thirty‐two papers met the inclusion criteria and we present the findings using a narrative synthesis. Only one paper identified explored this topic in Europe. Barriers and enablers are presented across four themes: (1) individual factors, (2) societal factors, (3) Gateway Providers and (4) treatment service factors. Mental health nurses, especially those working with young people, should be aware that adolescents are unlikely to perceive their substance use as problematic and rely on adults to access treatment. Access appears more difficult for females and socially marginalised youth. Various professionals direct young people towards treatment, but clear protocols are needed to encourage them to intervene, which could be an opportunity for nurses to be innovative and lead in this area. Services perceived as adolescent‐specific, youth‐friendly and flexible encourage attendance while the cost of treatment, including time off work and transport, function as barriers.
Highly Commended, BMA Medical Book Awards 2014This highly practical manual presents an ideal introduction to adolescent substance use. It offers invaluable guidance for all professionals involved with adolescents including social workers, health and social care professionals, youth workers, family support workers, teachers, counsellors, mental heal
Alcohol, cannabis, cocaine, heroin and benzodiazepines account for 95% of treatment cases in Ireland. This study examines first episode treatment data from the European Treatment Demand Protocol to examine access to services based on primary problem substance. The (N = 37,550) main presenting substances were alcohol (48.2%) and cannabis (21.4%). Alcohol had the highest proportion of women seeking treatment (37.6%) while cocaine had the lowest (19.0%). Alcohol cases were the oldest (40.7 years) while cannabis cases the youngest (22.9 years). Irish Travellers had higher rates of presentation for heroin and benzodiazepines use. Alcohol had the longest duration between first use and accessing treatment (24.2 years), while cannabis had the shortest (7.9 years); these differences were statistically different compared to all other substances. Alcohol cases were more often referred by medical sources and cannabis from criminal justice and community/social services. These findings emphasise that there were considerable periods between first use and first treatment and there are different demographic presentations between different substances.
15 January 2026 in International Journal of Drug Policy
Globally, opioid agonist treatment (OAT) is recognised as a cornerstone of evidence-based responses to opioid dependence. Many countries have expanded access by enabling nurses to prescribe methadone and buprenorphine, with consistent evidence of safety, effectiveness, and improved equity of access. Despite this precedent, Ireland has not introduced nurse prescribing of OAT. Drawing on policy reviews, communications, national strategy documents, legislation, parliamentary debates, international literature and media reports, this commentary positions this issue as an important initiative which has been excluded from Irish drug-policy. This commentary highlights a clinical and regulatory paradox: Irish nurses may prescribe controlled opioids for pain and palliative care for a person who is dependent on opioids, but are legally prohibited from prescribing the same medications for OAT. Independent reviews and government policy have recommended exploring nurse prescribing to address persistent workforce shortages. This commentary identifies how governance structures have marginalised nursing perspectives and mobilised evidence selectively, contributing to inaction. The authors propose that this case illustrates how existing approaches, varying accountability, and political framing shape policy decisions. With a new national drugs strategy in development, Ireland faces a choice: continue with non-inclusive, traditional governance or adopt inclusive, evidence-informed reform that aligns with international best practice.
The World Health Organization (WHO) describes neurodevelopmental disorders as behavioral and cognitive disorders that occur during a baby’s developmental period: these include autism spectrum disor...
13 July 2025 in Counselling and Psychotherapy Research